Maulasri Bhatta

Maulasri Bhatta is a Principal Scientist at Auron Therapeutics, Inc., since September 2022, having held previous positions as Senior Scientist II and Senior Scientist I in Translational Biology. Prior experience includes serving as HRI Scientist at Roswell Park Comprehensive Cancer Center, where research focused on tumor immune microenvironments using advanced techniques such as multispectral imaging. At Immune Modulatory Therapies, LLC, Maulasri contributed to novel cancer immunotherapy drug development and held both scientific and administrative roles. Education includes a PhD in Neuroscience from the University at Buffalo, where significant research involved endoplasmic reticulum stress and neurodegeneration. Additional experience includes teaching labs at the State University of New York at Buffalo and trainee work at the National Institute of Immunology.